EUVIMEDEUVIMED entdecken
Crossref

Sleeve gastrectomy in pediatric and transition age patients with Prader–Willi syndrome: a 5-year longitudinal study

Alessia Aureli iD, Francesco Carlomagno iD, Antonino Crinò iD, Sarah Bocchini iD, Sonia Battaglia, Daniela Camanni iD, Emanuela Ceriati iD, Michela Mariani iD, Stefano Delli Noci, Melania Manco iD, Francesco De Peppo iD, Andrea M Isidori iD und 2 weitere

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgag210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Alessia Aureli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Diabetology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome 00146, Italy. Hauptthemen laut MEDLINE: Prader-Willi Syndrome, Gastrectomy, Obesity, Morbid, Pediatric Obesity. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Bambino Gesù Children's Hospital, IRCCS and "Sapienza" University of Rome, Bambino Gesù Children’s Hospital, IRCCS and “Sapienza” University of Rome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the long-term effectiveness of laparoscopic sleeve gastrectomy (LSG) in pediatric and transition age patients with Prader–Willi syndrome (PWS).

Design

Single-center, longitudinal, retrospective cohort study.

Methods

We reviewed the electronic health records of 110 patients with PWS and 268 subjects undergoing LSG. We included 16 patients with PWS and severe obesity (PWS-LSG) and 32 matched non-syndromic patients with obesity (OB-LSG), both undergoing LSG, and 16 patients with PWS receiving lifestyle intervention only (PWS-LS). The primary endpoint was ΔBMI-SDS% at 5 years.

Results

In PWS-LSG, BMI-SDS decreased from 5.18 to an early nadir at 1-2 years (median ΔBMI-SDS% ∼−26%), then partially rebounded to 4.75 at 5 years, with ΔBMI-SDS% −16.9% (P = .012). Conventional metrics confirmed this attenuated response, with %BMI change −2.8% and absolute ΔBMI-SDS −1.10 at 5 years. In OB-LSG, BMI-SDS declined from 4.95 to 2.24, with larger and more sustained improvement (ΔBMI-SDS% −57.4%; P < .001 within-group; P = .002 vs PWS-LSG), corresponding to a %BMI change −40.1% and absolute ΔBMI-SDS −2.81 at 5 years. In PWS-LS, BMI-SDS increased from 2.25 to 3.19 (ΔBMI-SDS% + 36.4%, P = .003). The mean number of obesity-related comorbidities decreased in PWS-LSG (2.69 ± 1.66 to 1.94 ± 1.18; P = .041) and in OB-LSG (1.25 ± 0.88 to 0.56 ± 0.76; P < .001), but increased in PWS-LS (1.56 ± 0.96 to 2.44 ± 1.32; P = .004).

Conclusion

In PWS, LSG produces clinically relevant early weight loss with partial maintenance at 5 years, but markedly attenuated long-term benefit compared with non-syndromic peers. Nevertheless, when interpreted against the progressive worsening of obesity and cardiometabolic comorbidities observed with lifestyle intervention alone, LSG appears to modify disease trajectory in PWS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prader-Willi SyndromeGastrectomyObesity, MorbidPediatric ObesityHumansFemaleLongitudinal StudiesRetrospective StudiesChildMaleAdolescentChild, PreschoolBody Mass IndexTreatment OutcomeLaparoscopyWeight LossFollow-Up Studies

Stichwörter der Autor:innen

Prader–Willi syndromemetabolic disordersobesityobstructive sleep apneasleeve gastrectomy

Autor:innen und Institutionen

  • Endocrinology and Diabetology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome 00146, Italy.
  • Department of Experimental Medicine, 'Sapienza' University of Rome, Rome 00161, Italy.
  • Endo-ERN Centre 'Azienda Ospedaliero-Universitaria Policlinico Umberto I', Rome 00161, Italy.
  • Centre for Rare Diseases and Congenital Defects, Fondazione Policlinico Universitario 'A. Gemelli', Rome 00168, Italy.
  • General Paediatric Surgery Unit, Bambino Gesù Children's Hospital, IRCCS, Rome 00146, Italy.
  • Research Unit for Preventive and Predictive Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome 00146, Italy.

ORCID-Profile: Alessia Aureli, Francesco Carlomagno, Antonino Crinò, Sarah Bocchini, Daniela Camanni, Emanuela Ceriati, Michela Mariani, Melania Manco, Francesco De Peppo, Andrea M Isidori, Stefano Cianfarani, Danilo Fintini

Förderung

  • Bambino Gesù Children's Hospital, IRCCS and "Sapienza" University of Rome
  • Bambino Gesù Children’s Hospital, IRCCS and “Sapienza” University of Rome

Zitieren

APA

Aureli, A., Carlomagno, F., Crinò, A., Bocchini, S., Battaglia, S., Camanni, D., Ceriati, E., Mariani, M., Delli Noci, S., Manco, M., De Peppo, F., Isidori, A. M., Cianfarani, S., & Fintini, D. (2026). Sleeve gastrectomy in pediatric and transition age patients with Prader–Willi syndrome: a 5-year longitudinal study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag210

Vancouver

Aureli A, Carlomagno F, Crinò A, Bocchini S, Battaglia S, Camanni D, et al. Sleeve gastrectomy in pediatric and transition age patients with Prader–Willi syndrome: a 5-year longitudinal study. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag210

BibTeX
@article{Aureli2026,
  author = {Aureli, Alessia and Carlomagno, Francesco and Crinò, Antonino and Bocchini, Sarah and Battaglia, Sonia and Camanni, Daniela and Ceriati, Emanuela and Mariani, Michela and Delli Noci, Stefano and Manco, Melania and De Peppo, Francesco and Isidori, Andrea M and Cianfarani, Stefano and Fintini, Danilo},
  title = {Sleeve gastrectomy in pediatric and transition age patients with Prader–Willi syndrome: a 5-year longitudinal study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgag210}
}
Kostenlos starten →